(주)에스와이피 ㅣ 에스와이피 특허법률사무소

: LOGIN KOREAN

About Us

Our Team

Professional Competence

IP1 Street

NEWS

How to Get Here

NEWS

Home NEWS

2023-06-09
DEMO DAY, a company participating in the BioCore project of …

2022. Dec. 20. On December 15, companies participating in the BioCore project of Pasteur Research Institute Korea (five companies, including Selenjin), conducted IR presentations to bio-specialized in...
2023-06-09
SYP Co., Ltd. Receives "Grand Prize" in 2022 for Best Practi…

2022. Nov. 21. SYP Co., Ltd. won the "Grand Prize" at the "2022 Best Practices Sharing Meeting for Technology Commercialization of Special R&D Zones" held on November 18.The grand prize winner, SY...
2023-06-09
'Helping doctor start-ups'...Participated in symposiums by t…

2022.Nov. 11.SYP Co., Ltd. is a director of the "Korea Medical Start-up Research Association" and attended the 2022 K-Bio Healthcare Industry Revitalization Symposium held by the research association ...
2023-06-09
SYP Co., Ltd. relocated to Seoul headquarters (Gangnam-gu fo…

2022. Aug. 18.SYP Seoul headquarters expansion relocationWe are informing you of the relocation of the SYP Seoul headquarters as follows. The changed address is located on the street of a designated e...
2023-06-09
BlueLeo-Clio Co., Ltd. is carrying out a regional specializa…

2022.Aug. 07.This is an article on BlueLeo, a medical device company specialized in investment and commercialization support by SWP.BlueLeo Co., Ltd. developed and introduced the world's first electri...
2023-06-09
Hey VC-based IR Demo Day Held

2022. July. 19SYP Co., Ltd. operates the "Hey VC Platform (www.heyvc.co.kr )" to improve the corporate value of startups and attract investment, and held IR Demo Day at the Unicorn Bridge IR Studio in...
2023-06-09
Jaein R&P Co., Ltd. "A natural anti-cancer drug that collect…

2022. June. 20This is an article about Jaein R&P, which is supported by SYP for investment and commercialization.Cancer is considered the most feared disease today. It's hard to find and treatment...
2023-06-09
MediHelpline Inc. Visible 'Phase 3 Clinical' New Drug for De…

2022.June. 20.This is an article on MediHelpline, which SYP is supporting investment and commercialization. "MediHelpline is developing a new drug for degenerative brain diseases with autophagy-induce...

Search